Compound Detail
CHEMBL403065
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)(c1cc(-c2cccc(-c3ccc(C(=O)NC4CC4)[n+]([O-])c3)c2)c2ncccc2c1)S(C)(=O)=O
Basic Information
| ChEMBL ID | CHEMBL403065 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GQDBCQQOEJGUPN-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
2
PK Parameters
4
Publications
0
Known Names
Molecular Properties
501.6
MW (Da)
4.37
ALogP
5
HBA
1
HBD
103.1
PSA (Ų)
0.31
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.77
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 8.77 | 8.77 | 1.7 | 1 |
| Blood CHEMBL613416 | IC50 | 6.4 | 6.4 | 400.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 100.0 | % | Rattus norvegicus |
| T1/2 | 6.5 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 1.7 | nM | 8.77 | Inhibition of PDE4 expressed in SF9 cells | 18207397 |
| Blood | IC50 | = | 400.0 | nM | 6.4 | Inhibition of LPS-stimulated TNFalpha release in human whole blood | 18207397 |
| Cytochrome P450 2C9 | IC50 | = | 4000.0 | nM | 5.4 | Inhibition of CYP2C9 | 18207397 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Rattus norvegicus | 2 |
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Unchecked | 1 |
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Blood | 1 |
| 18207397 | 10.1016/j.bmcl.2008.01.004 | Cytochrome P450 2C9 | 1 |
Data from ChEMBL 36 via Core Engine